BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 7857510)

  • 1. Inhibition of MAO and COMT by hypericum extracts and hypericin.
    Thiede HM; Walper A
    J Geriatr Psychiatry Neurol; 1994 Oct; 7 Suppl 1():S54-6. PubMed ID: 7857510
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of MAO by fractions and constituents of hypericum extract.
    Bladt S; Wagner H
    J Geriatr Psychiatry Neurol; 1994 Oct; 7 Suppl 1():S57-9. PubMed ID: 7857511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro receptor binding and enzyme inhibition by Hypericum perforatum extract.
    Cott JM
    Pharmacopsychiatry; 1997 Sep; 30 Suppl 2():108-12. PubMed ID: 9342770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of cytokine expression by hypericum extract.
    Thiele B; Brink I; Ploch M
    J Geriatr Psychiatry Neurol; 1994 Oct; 7 Suppl 1():S60-2. PubMed ID: 7857513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of hypericum extract on the expression of serotonin receptors.
    Müller WE; Rossol R
    J Geriatr Psychiatry Neurol; 1994 Oct; 7 Suppl 1():S63-4. PubMed ID: 7857514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperforin as a possible antidepressant component of hypericum extracts.
    Chatterjee SS; Bhattacharya SK; Wonnemann M; Singer A; Müller WE
    Life Sci; 1998; 63(6):499-510. PubMed ID: 9718074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monoamine Oxidase-A Inhibition and Associated Antioxidant Activity in Plant Extracts with Potential Antidepressant Actions.
    Herraiz T; Guillén H
    Biomed Res Int; 2018; 2018():4810394. PubMed ID: 29568754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activity profiles of two hyperforin-containing hypericum extracts in behavioral models.
    Bhattacharya SK; Chakrabarti A; Chatterjee SS
    Pharmacopsychiatry; 1998 Jun; 31 Suppl 1():22-9. PubMed ID: 9684944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of hypericum extract LI 160 compared with maprotiline on resting EEG and evoked potentials in 24 volunteers.
    Johnson D; Ksciuk H; Woelk H; Sauerwein-Giese E; Frauendorf A
    J Geriatr Psychiatry Neurol; 1994 Oct; 7 Suppl 1():S44-6. PubMed ID: 7857508
    [TBL] [Abstract][Full Text] [Related]  

  • 10. St. John's wort.
    Med Lett Drugs Ther; 1997 Nov; 39(1014):107-8. PubMed ID: 9398822
    [No Abstract]   [Full Text] [Related]  

  • 11. Pharmacological profile of hypericum extract. Effect on serotonin uptake by postsynaptic receptors.
    Perovic S; Müller WE
    Arzneimittelforschung; 1995 Nov; 45(11):1145-8. PubMed ID: 8929227
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of hypericum extract (LI 160) in biochemical models of antidepressant activity.
    Müller WE; Rolli M; Schäfer C; Hafner U
    Pharmacopsychiatry; 1997 Sep; 30 Suppl 2():102-7. PubMed ID: 9342769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmaceutical quality of hypericum extracts.
    Wagner H; Bladt S
    J Geriatr Psychiatry Neurol; 1994 Oct; 7 Suppl 1():S65-8. PubMed ID: 7857515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypericum LI 160 inhibits uptake of serotonin and norepinephrine in astrocytes.
    Neary JT; Bu Y
    Brain Res; 1999 Jan; 816(2):358-63. PubMed ID: 9878826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of hypericum extract on the sleep EEG in older volunteers.
    Schulz H; Jobert M
    J Geriatr Psychiatry Neurol; 1994 Oct; 7 Suppl 1():S39-43. PubMed ID: 7857507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyperforin represents the neurotransmitter reuptake inhibiting constituent of hypericum extract.
    Müller WE; Singer A; Wonnemann M; Hafner U; Rolli M; Schäfer C
    Pharmacopsychiatry; 1998 Jun; 31 Suppl 1():16-21. PubMed ID: 9684943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of a methanolic extract and a hyperforin-enriched CO2 extract of St. John's Wort (Hypericum perforatum) on intracerebral field potentials in the freely moving rat (Tele-Stereo-EEG).
    Dimpfel W; Schober F; Mannel M
    Pharmacopsychiatry; 1998 Jun; 31 Suppl 1():30-5. PubMed ID: 9684945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antidepressant activity of hypericum perforatum and hyperforin: the neglected possibility.
    Chatterjee SS; Nöldner M; Koch E; Erdelmeier C
    Pharmacopsychiatry; 1998 Jun; 31 Suppl 1():7-15. PubMed ID: 9684942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical investigation of the antidepressant effectiveness of hypericum.
    Harrer G; Schulz V
    J Geriatr Psychiatry Neurol; 1994 Oct; 7 Suppl 1():S6-8. PubMed ID: 7857512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacodynamic effects of two different hypericum extracts in healthy volunteers measured by quantitative EEG.
    Schellenberg R; Sauer S; Dimpfel W
    Pharmacopsychiatry; 1998 Jun; 31 Suppl 1():44-53. PubMed ID: 9684947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.